超越:肝脏内胆固醇病的不断变化的分子景观
Ilaria Ziccardi1, Michela Zorzi1, Adamo Pio d'Adamo1,2
1Institute for Maternal and Child Health-IRCCS "Burlo Garofolo", 34137 Trieste, Italy.
Diagnostics (Basel, Switzerland)
|March 14, 2026
概括
遗传学正在彻底改变胆固醇性肝病的诊断和管理. 下一代测序 (NGS) 现在指导了针对进展性家族性肝内胆固醇症 (PFIC) 等疾病的个性化治疗方法.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 医学遗传学 医学遗传学
- 基因组医学是基因组医学.
背景情况:
- 胆固醇病,一组肝脏疾病,损害了胆汁的流动.
- 基因组技术正在改变对胆固醇性疾病的理解.
- 渐进性家族性肝内胆固醇症 (PFIC) 和成人发病胆固醇症 (AOCD) 被视为一个频谱.
研究的目的:
- 审查遗传学对胆固醇病原生理学,诊断和治疗的影响.
- 为了突出胆固醇疾病的扩展分子分类.
- 讨论在管理胆固醇病的过程中向精准医学的转变.
主要方法:
- 审查当前关于胆固醇病的遗传进展的文献.
- 分析下一代测序 (NGS) 在诊断中的应用.
- 检查基因型引导的治疗策略.
主要成果:
- 遗传学已经将PFIC的分子鼻科扩展到13种类型.
- 传送器,紧密连接和核受体的缺陷导致临床变异性.
- NGS正在越来越多地取代肝脏活检作为病因诊断.
- 特定的遗传特征决定了人们是否有资格接受IBAT抑制剂等向疗法.
结论:
- 基因洞察力正在重新定义胆固醇病的诊断和管理.
- 个性化医疗方法正在出现,由分子精度驱动.
- 从支持性护理向向性治疗的过渡在胆固醇性肝病治疗中很明显.
相关概念视频
Chronic Pancreatitis I: Introduction
842
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
842
Hepatic Drug Clearance: Role of Transporters
359
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
359
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
310
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
310
Chronic Pancreatitis II: Collaborative Care
456
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
456
Hepatic Drug Excretion: Enterohepatic Cycling
3.2K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
3.2K
Hepatic Portal System
7.3K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
7.3K


